Manufacturing The 3rd Biologics Revolution

First there were prophylactic vaccines. Then there were antibodies. The next biologics revolution will bring therapeutic vaccines that enable the best of both worlds. While low immunogenicity, established disease burden, and the immunosuppressive tumor microenvironment have proven early development challenges, the therapeutic vaccine revolution is happening now, and it's gaining steam on the back of advances in RNA technology.